Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01-GY-2022)
Received: 3 May 2022
Accepted: 2 November 2022
First Online: 9 December 2022
: The study will be performed in line with the Declaration of Helsinki. The study procedure and materials have been reviewed and approved by the Ethics Committee of the Medical Council Westfalen-Lippe and the Medical Faculty of the Westfälischen Wilhelms-Universität Münster, Germany, (Trial Nr. 2021-518-f-S) and the Ethical Committee of the Medical Faculty at the Goethe University Frankfurt am Main, Germany (Trial Nr. 2021-559). At the first appointment, participants are informed about the study by the study physician and can discuss any questions or other issues they may have. The physician then obtains written informed consent if participants agree to take part. Since participants are suspected of dementia, the capability to consent could be an issue. To support the ability to consent, measures to increase the ability of people with dementia to consent to medical interventions according to the German AWMF S2k guidelines to medical procedures will be used. Patients who cannot consent with the help of these supporting measures are excluded from the study as long as no proxy is available to consent in his/her stead. Nonetheless, consent by proxy still requires each patient’s assent. Visible or audible lack of assent at any point of the study will result in the participant’s withdrawal.
: Informed consent to publish the anonymized data was gained from all participants.
: The authors declare that they have no competing interests.